What's Happening?
In January 2023, the U.S. revised its perinatal HIV guidelines to support shared decision-making in infant feeding, ending the categorical prohibition of breastfeeding for people living with HIV (PLHIV). This change aligns with long-standing scientific
evidence showing low transmission risk with antiretroviral therapy. However, the uptake of these guidelines has been inconsistent, with clinicians expressing uncertainty and patients reporting limited changes in counseling. The shift requires dismantling the institutional and cultural frameworks that supported the prohibition, emphasizing the need for equity-centered training and advocacy for the repeal of HIV criminalization statutes.
Why It's Important?
The guideline change represents a significant shift in public health policy, acknowledging the scientific evidence that supports safe breastfeeding practices for PLHIV. This development is crucial for advancing reproductive justice and autonomy for marginalized communities disproportionately affected by HIV. The change also highlights the need for systemic reforms in healthcare practices and policies to ensure equitable access to care and support for PLHIV. By addressing the stigma and legal barriers associated with HIV, the revised guidelines aim to improve health outcomes for mothers and infants.
What's Next?
The implementation of the new guidelines will require ongoing efforts to educate healthcare providers and dismantle the entrenched beliefs and practices that supported the prohibition. Advocacy for the repeal of HIV criminalization statutes and the development of privacy-protective research infrastructure will be essential to support PLHIV. Additionally, community engagement and partnership with affected populations will be critical to ensuring that the guidelines are effectively implemented and that trust is rebuilt between clinicians and patients.
